| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
in00005764421 |
| 005 |
20260327154430.9 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
190130s2019 mau ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d YDX
|d EBLCP
|d OPELS
|d UKMGB
|d OCLCF
|d BRX
|d N$T
|d OCLCQ
|d CASUM
|d OCLCO
|d OCLCA
|d OCLCQ
|d UX1
|d VT2
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|d OCLCL
|d OCLCQ
|d CLOUD
|d OCLCQ
|d OCLCL
|
| 015 |
|
|
|a GBB928456
|2 bnb
|
| 015 |
|
|
|a GBB932330
|2 bnb
|
| 016 |
7 |
|
|a 019235740
|2 Uk
|
| 019 |
|
|
|a 1083685686
|a 1125776350
|a 1235824256
|a 1243135107
|
| 020 |
|
|
|a 9780128167618
|q (electronic bk.)
|
| 020 |
|
|
|a 0128167610
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128167601
|q (electronic bk.)
|
| 020 |
|
|
|a 0128167602
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)1083641420
|z (OCoLC)1083685686
|z (OCoLC)1125776350
|z (OCoLC)1235824256
|z (OCoLC)1243135107
|
| 037 |
|
|
|a 9780128167618
|b Ingram Content Group
|
| 050 |
|
4 |
|a QH442
|
| 060 |
|
4 |
|a W1
|b ME9615K v.616 2019
|
| 060 |
|
4 |
|a QU 25
|
| 072 |
|
7 |
|a SCI
|x 013060
|2 bisacsh
|
| 072 |
|
7 |
|a TEC
|x 009010
|2 bisacsh
|
| 072 |
|
7 |
|a PSD
|2 bicssc
|
| 082 |
0 |
4 |
|a 572.86
|2 23
|
| 049 |
|
|
|a TXAM
|
| 245 |
0 |
0 |
|a CRISPR-Cas Enzymes /
|c edited by Scoll Bailey.
|
| 250 |
|
|
|a First edition.
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Academic Press,
|c 2019.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in enzymology,
|x 0076-6879 ;
|v volume 616
|
| 504 |
|
|
|a Includes bibliographical references at the end of each chapter and indexes.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed January 31, 2019).
|
| 505 |
0 |
|
|a Front Cover; CRISPR-Cas Enzymes; Copyright; Contents; Contributors; Preface; Chapter One: Predicting and visualizing features of CRISPR-Cas systems; 1. Introduction; 2. Identify and characterize CRISPR-Cas system enzymes; 2.1. Requirements; 2.2. Metagenomic preparation; 2.3. Annotation; 2.4. CRISPR-Cas system identification and typing; 3. Visualize and characterize the repeat-spacer array; 3.1. Requirements; 3.2. Extract and visualize the repeat spacer array; 3.3. Determine CRISPR locus orientation; 4. crRNA guides; 4.1. Requirements; 4.2. tracrRNA identification
|
| 505 |
8 |
|
|a 4.3. crRNA boundaries and tracrRNA identification through RNASeq5. Predicting the PAM sequence; 5.1. Requirements; 5.2. Procedure; Acknowledgments; References; Chapter Two: Reconstitution and biochemical characterization of ribonucleoprotein complexes in Type I-E CRISPR-Cas systems; 1. Introduction; 1.1. In vivo assay for Cascade- and Cas3-mediated target plasmid loss; 1.2. Cloning, expression, and purification of the T. fusca Cascade complex; 2. Electrophoretic mobility shift assay; 2.1. Chemical probing
|
| 505 |
8 |
|
|a 2.2. Assemble TfuCascade/seed-bubble, TfuCascade/R-loop, and TfuCascade/R-loop/Cas3 complexes for structural analysis3. Conclusion; Acknowledgments; References; Further reading; Chapter Three: Sortase-mediated fluorescent labeling of CRISPR complexes; 1. Introduction; 2. Methods; 2.1. Overview; 2.2. Buffers; 2.2.1. Sortase purification buffers; 2.2.2. Cas1-Cas2 purification buffers; 2.2.3. Cascade purification buffers; 2.2.4. Cas3 purification buffers; 2.3. Sortase purification; 2.4. Purification of Tfu Cascade complexes and subunits for N-terminal sortase labeling
|
| 505 |
8 |
|
|a 2.4.1. Cas1-Cas2 purification and sortase labeling of Cas22.4.2. Cascade purification and sortase labeling of Cse1; 2.5. Purification of Tfu Cascade complexes and subunits for C-terminal sortase labeling; 2.5.1. Cas3 purification and sortase labeling; 2.6. Optimization of sortase-mediated fluorescent labeling; 3. Applications; 3.1. Single-molecule imaging of fluorescent Cas1-Cas2, Cascade, and Cas3 on DNA curtains; 4. Notes; Acknowledgments; Funding; References; Chapter Four: Fluorescence-based methods for measuring target interference by CRISPR-Cas systems; 1. Introduction
|
| 505 |
8 |
|
|a 2. Fluorescence-based strategies for measuring CRISPR interference2.1. Design and development of GFP-reporter plasmid pACYC-GFP; 2.2. Validation of GFP-based plasmid-loss assay; 3. Measurement of CRISPR interference in colonies and liquid culture; 3.1. Addition of CRISPR target to pACYC-GFP; 3.1.1. Equipment; 3.1.2. Buffers and reagents; 3.1.3. Procedure; 3.2. Detection of plasmid levels in bacterial colonies; 3.2.1. Equipment; 3.2.2. Buffers and reagents; 3.2.3. Procedure; 3.3. Measurement of CRISPR interference efficiency in liquid cultures; 3.3.1. Equipment; 3.3.2. Buffers and reagents
|
| 520 |
|
|
|a CRISPR-Cas Enzymes, Volume 616, the latest release in the Methods in Enzymology series, continues the legacy of this premier serial with quality chapters authored by leaders in the field. Topics covered in this release include CRISPR bioinformatics, A method for one-step assembly of Class 2 CRISPR arrays, Biochemical reconstitution and structural analysis of ribonucleoprotein complexes in Type I-E CRISPR-Cas systems, Mechanistic dissection of the CRISPR interference pathway in Type I-E CRISPR-Cas system, Site-specific fluorescent labeling of individual proteins within CRISPR complexes, Fluorescence-based methods for measuring target interference by CRISPR-Cas systems, Native State Structural Characterization of CRISRP Associated Complexes using Mass Spectrometry, and more.
|
| 650 |
|
0 |
|a Genetic engineering.
|
| 650 |
|
0 |
|a CRISPR (Genetics)
|
| 650 |
|
0 |
|a Genomics.
|
| 650 |
|
0 |
|a Endonucleases.
|
| 650 |
|
0 |
|a Restriction enzymes, DNA.
|
| 650 |
|
0 |
|a CRISPR-associated protein 9.
|
| 650 |
1 |
2 |
|a CRISPR-Associated Protein 9
|
| 650 |
2 |
2 |
|a CRISPR-Cas Systems
|
| 650 |
2 |
2 |
|a Clustered Regularly Interspaced Short Palindromic Repeats
|
| 650 |
2 |
2 |
|a Gene Editing
|x methods
|
| 650 |
|
2 |
|a Genomics
|
| 650 |
|
2 |
|a Endonucleases
|
| 650 |
|
2 |
|a DNA Restriction Enzymes
|
| 650 |
|
6 |
|a Génomique.
|
| 650 |
|
6 |
|a Endonucléases.
|
| 650 |
|
6 |
|a Enzymes de restriction.
|
| 650 |
|
6 |
|a Protéine-9 associée à CRISPR.
|
| 650 |
|
6 |
|a Systèmes CRISPR-Cas.
|
| 650 |
|
6 |
|a CRISPR (Génétique)
|
| 650 |
|
7 |
|a SCIENCE
|x Chemistry
|x Industrial & Technical.
|2 bisacsh
|
| 650 |
|
7 |
|a TECHNOLOGY & ENGINEERING
|x Chemical & Biochemical.
|2 bisacsh
|
| 650 |
|
7 |
|a CRISPR-associated protein 9
|2 fast
|
| 650 |
|
7 |
|a CRISPR (Genetics)
|2 fast
|
| 650 |
|
7 |
|a Endonucleases
|2 fast
|
| 650 |
|
7 |
|a Genetic engineering
|2 fast
|
| 650 |
|
7 |
|a Genomics
|2 fast
|
| 650 |
|
7 |
|a Restriction enzymes, DNA
|2 fast
|
| 655 |
|
7 |
|a Electronic books.
|2 local
|
| 655 |
|
4 |
|a Internet Resources.
|
| 700 |
1 |
|
|a Bailey, Scott,
|e editor.
|
| 710 |
2 |
|
|a ScienceDirect (Online service)
|
| 776 |
0 |
8 |
|i Print version:
|z 0128167602
|z 9780128167601
|w (OCoLC)1044862597
|
| 830 |
|
0 |
|a Methods in enzymology ;
|v v. 616.
|
| 856 |
4 |
0 |
|u http://proxy.library.tamu.edu/login?url=https://www.sciencedirect.com/science/bookseries/00766879/616
|z Connect to the full text of this electronic book
|t 0
|
| 955 |
|
|
|a Elsevier ScienceDirect 2026-2027
|
| 994 |
|
|
|a 92
|b TXA
|
| 999 |
f |
f |
|i 4e9e009f-0c87-4a59-9397-195084b8e1c2
|s faccfece-bf47-4957-afc7-c7f033f0901f
|t 0
|
| 952 |
f |
f |
|a Texas A&M University
|b College Station
|c Electronic Resources
|s www_evans
|d Available Online
|t 0
|e QH442
|h Library of Congress classification
|
| 998 |
f |
f |
|a QH442
|t 0
|l Available Online
|